The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world

10.1007/s11684-020-0767-8

10.1038/s41586-020-2012-7

10.1056/NEJMoa2001017

10.1097/00001432-200404000-00013

10.1016/S0140-6736(03)14562-X

10.1073/pnas.0506735102

10.1016/j.virusres.2015.05.006

10.1146/annurev-micro-020518-115759

10.1056/NEJMoa1401505

10.1128/mBio.00473-12

worldometers.info.Coronavirus death rate 2020. URLhttps://www.worldometers.info/coronavirus/[accessed on 14 May 2020].

10.1016/j.jinf.2020.03.005

10.1016/S0140-6736(20)30566-3

worldometers.info.Countries where Coronavirus has spread 2020. URLhttps://www.worldometers.info.coronavirus/countries‐where‐coronavirus‐has‐spread/[accessed on 15 May 2020].

WHO.int.WHO Director‐General's opening remarks at the media briefing on COVID‐19 11 March 2020 2020. URLhttps://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐media‐briefing‐on‐covid‐19‐‐‐11‐march‐2020[accessed on 21 April 2020].

10.1038/d41573-020-00073-5

10.1016/S0140-6736(20)30763-7

10.1126/science.abb2507

10.1038/s41564-020-0688-y

10.1038/nature02463

10.1128/JVI.78.11.5612-5618.2004

10.1016/S1473-3099(20)30196-1

10.1016/j.micinf.2020.02.006

10.1186/1743-422X-11-82

10.1073/pnas.0409065102

10.1016/j.chom.2016.01.007

10.1128/JVI.06048-11

10.2217/fvl-2016-0070

10.1080/21645515.2017.1383575

10.1016/S0140-6736(20)30183-5

10.1371/journal.pone.0035421

10.1038/ni.2039

10.1038/nbt.1635

10.1016/j.actbio.2018.08.033

10.1016/j.immuni.2020.03.007

PublicHeath.org.How Vaccines Work 2020. URLhttps://www.publichealth.org/public‐awareness/understanding‐vaccines/vaccines‐work/[accessed on 16 April 2020].

10.1007/s12250-018-0009-2

Codagenix.com.Platform Overview 2020. URLhttps://codagenix.com/technology/platform‐overview/[accessed on 16 April 2020].

10.1177/135965350701200702

10.1126/science.abc1932

10.1016/j.bcp.2016.05.001

10.1080/21645515.2016.1216287

10.1016/j.vaccine.2017.06.003

10.1016/j.smim.2013.05.001

10.1016/j.jconrel.2019.04.043

10.1016/j.vaccine.2012.04.060

10.1016/S0140-6736(17)31665-3

10.1016/j.vaccine.2008.09.026

10.1007/978-1-4939-6481-9_1

10.3389/fimmu.2018.01568

10.1080/14760584.2017.1394842

10.1016/j.coi.2016.05.014

10.1586/erv.13.15

10.1080/21645515.2017.1342021

10.1016/S0140-6736(16)32621-6

Doremalen N, 2020, A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques, Sci Adv

10.1097/MCP.0b013e328351f8d4

10.1016/j.vaccine.2009.03.080

10.1038/nm.3702

10.1038/mt.2013.284

10.1093/infdis/jiy639

10.1016/S1473-3099(20)30160-2

10.1098/rstb.2016.0295

WHO.int.Four countries in the African region license vaccine in milestone for ebola prevention.https://www.who.int/news‐room/detail/14‐02‐2020‐four‐countries‐in‐the‐african‐region‐license‐vaccine‐in‐milestone‐for‐ebola‐prevention[accessed on 10 May 2020].

10.1093/infdis/jiz070

10.1098/rstb.2011.0100

10.4103/0022-3859.173187

10.3389/fmed.2018.00297

10.1016/S2214-109X(18)30346-2

10.1056/NEJMp2005630

10.1016/j.ymthe.2017.11.017

10.3389/fmicb.2017.00605

10.1158/1078‐0432.CCR‐20‐0414

WilsonJ.In pictures: the Imperial lab developing a COVID‐19 vaccine 2020. URLhttps://www.imperial.ac.uk/news/196313/in‐pictures‐imperial‐developing‐covid19‐vaccine/[accessed on 16 April 2020].

bristol.ac.uk.New vaccine platform used to develop COVID‐19 candidates 2020. URLhttp://www.bristol.ac.uk.news/2020/april/covid‐19‐vaccine‐platform.html[accessed on 20 May 2020].

10.1126/sciadv.aaw2853

DioSynVax.DioSynVax COVID Response 2020. URLhttps://www.worldometers.info/coronavirus/[accessed on 15 May 2020].

covid19vaccinetrial.co.uk.COVID‐19 vaccine trial 2020. URLhttps://covid19vaccinetrial.co.uk

10.1371/journal.pone.0040385

Doremalen N, 2019, A single‐dose ChAdOx1‐vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters, PLoS Negl Trop Dis, 13, e0007462, 10.1371/journal.pntd.0007462

10.1016/j.vaccine.2019.10.102

10.1016/j.ebiom.2018.02.011

clinicaltrials.gov.A clinical trial to determine the safety and immunogenicity of healthy candidate MERS‐CoV vaccine (MERS002) 2019. URLhttps://clinicaltrials.gov.ct2/show/NCT04170829[accessed on 5 June 2020].

clinicaltrials.gov.Safety and immunogenicity of a candidate MERS‐CoV vaccine (MERS001) 2019.https://clinicaltrials.gov.ct2/show/NCT03399578[accessed on 16 May 2020].

clinicaltrials.gov.Study of a Candidate COVID‐19 vaccine (COV001) 2020.https://clinicaltrials.gov/ct2/show/NCT04324606?cond=covid‐19+vaccine&draw=2&rank=1[accessed on 16 May 2020].

covid19vaccinetrial.co.uk.How long will it take to get the Oxford vaccine to deployment?2020. URLhttps://covid19vaccinetrial.co.uk/blog‐how‐long‐will‐it‐take‐get‐oxford‐vaccine‐deployment[accessed on 5 June 2020].

10.1016/j.vaccine.2019.04.074

10.1038/nature21428

WHO.DRAFT landscape of COVID‐19 candidate vaccines 2020. URLhttps://www.who.int/blueprint/priority‐diseases/key‐action/novel‐coronavirus‐landscape‐ncov.pdf?ua=1[accessed on 5 May 2020].

BioNTech.BioNTech Pipeline 2019. URLhttps://biontech.de/science/pipeline[accessed on 5 June 2020].

Inovio.Inovio Pharmaceuticals selected by CEPI to develop vaccine against new coronavirus 2020.http://ir.inovio.com/news‐and‐media/news/press‐release‐details/2020/Inovio‐Selected‐by‐CEPI‐to‐Develop‐Vaccine‐Against‐New‐Coronavirus/default.aspx[accessed on 15 May 2020].

10.1016/S1473-3099(19)30397-4

10.1186/s12967-019-02133-w

FergusonN LaydonD Nedjati GilaniG ImaiN AinslieK BaguelinMet al.Report 9: Impact of non‐pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand 2020.

10.1136/bmj.m1492

10.1016/S0140-6736(20)30735-2

10.1126/science.abb5793

10.1056/NEJMoa1411627

10.3389/fmicb.2020.00372